Shikonin extracted from medicinal Chinese herbs exerts anti-inflammatory effect via proteasome inhibition
- 1 May 2011
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 658 (2-3) , 242-247
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Physiological levels of ATP negatively regulate proteasome functionCell Research, 2010
- Clinical development of novel proteasome inhibitors for cancer treatmentExpert Opinion on Investigational Drugs, 2009
- Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivoInternational Journal of Cancer, 2009
- The Isolation and Characterization of Murine MacrophagesCurrent Protocols in Immunology, 2008
- The IκB kinase complex: master regulator of NF-κB signalingImmunologic Research, 2008
- The Proteasome as a Lipopolysaccharide-Binding Protein in Macrophages: Differential Effects of Proteasome Inhibition on Lipopolysaccharide-Induced Signaling EventsThe Journal of Immunology, 2003
- NF-κB as a therapeutic target in cancerTrends in Molecular Medicine, 2002
- Cellular pharmacology studies of shikonin derivativesPhytotherapy Research, 2002
- The TNF and TNF Receptor SuperfamiliesCell, 2001
- Granulocyte Apoptosis and Its Role in the Resolution and Control of Lung InflammationAmerican Journal of Respiratory and Critical Care Medicine, 1999